Utipro® Plus AF Named Best Women’s Product at the OTC Awards 2026
Utipro® Plus AF has been named Best Women's Product at the OTC & Retail Pharmacy Product Awards 2026 in Ireland, collected by our partner Pamex Limited. [...]
Partner Devicare, S.L.
We would like to announce our new partnership with Devicare, S.L., to bring Utipro Plus AF into the Spanish market! We’re excited about this new alliance and grateful for the trust placed in us. Interested in exploring business opportunities with us? Contact us! https://noventure.com/contact-us [...]
UTIPRO® PLUS AF reaches Central Asia
We are happy to inform that Utipro® Plus AF is ready to land in Central Asia thanks to its very recent registration in Kazakhstan. All evidence supporting the product has been evaluated by the Kazakh Ministry of Health who validated the CE certification of the product and accepted its medical [...]
New publication for UTIPRO® PLUS / UTIPRO® PLUS AF (The UTISWISS Study)
We are happy to announce the publication of new evidence on the benefit of an antibiotic-free approach (xyloglucan, hibiscus and propolis for oral administration) in the management of uncomplicated urinary tract infections. The objective of this very recent publication in Uro was the evaluation of the efficacy of an oral [...]
New publication on Recurrent UTI: Q&A on Clinical Practice1
A novel mode of action to promote antibiotic-sparing approach to Recurrent UTIs: Questions and Answers on Clinical Practice1 Consultations for recurrent urinary tract infections (rUTIs) in everyday clinical practice range from 1% to 6% of all medical visits with high social and personal associated costs, such as prescriptions, hospital expenses, [...]
New publication for Utipro® Plus / Utipro® Plus AF
Let’s celebrate 2022 with a new paper on Utipro® Plus and Utipro® Plus AF!! We are pleased to announce the publication of a meta-analysis in which the benefit of the combination of a mucoprotectant (xyloglucan or an equivalent substance), hibiscus and propolis in the management of uncomplicated urinary tract infections [...]
Impact of Covid-19 on UTI and antibiotic stewardship (T. Cai et al. on Uro 2022)
Several recent studies showed that, despite the overall percentage of bacterial co-infection among COVID-19 patients was low, the use of antibiotic was high. This motivated a team of urologists led by Prof. Tommaso Cai, from the Department of Urology, Santa Chiara Regional Hospital, to discuss the role of managing urinary [...]
First launch of UTIPRO® PLUS AF in EUROPE
We are pleased to announce the launch of UTIPRO® PLUS AF in Portugal. Portugal is the first European country in which UTIPRO® PLUS AF has been launched in its composition free from ingredients of animal origin. The product is distributed by Sangool, a Portuguese company specialized in the detailing and the [...]
UTIPRO® PLUS AF strengthens its presence in EUROPE
We are pleased to announce the launch of UTIPRO® PLUS AF in the Republic of Ireland. UTIPRO® PLUS AF, in its composition free from ingredients of animal origin, has been recently launched in the Republic of Ireland, thus further enlarging its presence across Europe. The product is distributed by Pamex, [...]
Uncomplicated Urinary Tract Infection in Adults – Noventure new Publication
We are glad inform you about a recent publication to further support the usefulness of mucoprotection in the relief of symptoms and in the prevention of recurrences in uncomplicated UTIs The trial “Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults“ has [...]